AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

StayHappi Gliclazide+Metformin 60mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sarvagunaushdhi Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview StayHappi Gliclazide+Metformin 60mg/500mg Tablet

DiabetaComb 60mg/500mg tablets, a dual-action antidiabetic medication, combine gliclazide and metformin to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Administer DiabetaComb with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Common side effects include hypoglycemia (low blood sugar – symptoms include sweating, dizziness, headache, and tremors), constipation, and nausea. Recognize hypoglycemia symptoms and carry a fast-acting glucose source (e.g., sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, diarrhea, stomach upset, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any heart conditions before starting treatment; pregnancy or breastfeeding requires medical consultation. Regular blood sugar checks and potential blood tests (blood cell counts, liver function) may be recommended by your doctor.

Uses of StayHappi Gliclazide+Metformin 60mg/500mg Tablet

Adult-onset diabetes

Major Benefits of StayHappi Gliclazide+Metformin 60mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the StayHappi Gliclazide+Metformin 60mg/500mg tablet whole; do not chew, crush, or break it. Administer this medication with food.

Common Side effects of StayHappi Gliclazide+Metformin 60mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use StayHappi Gliclazide+Metformin 60mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the StayHappi Gliclazide+Metformin 60mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How StayHappi Gliclazide+Metformin 60mg/500mg Tablet works:

StayHappi tablets, containing 60mg gliclazide and 500mg metformin, offer a dual-action approach to blood sugar management by combining these two established antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking StayHappi Gliclazide+Metformin 60mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of StayHappi Gliclazide+Metformin 60mg/500mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of StayHappi Gliclazide+Metformin 60mg/500mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use StayHappi Gliclazide+Metformin 60mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients experiencing severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use StayHappi Gliclazide+Metformin 60mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take StayHappi Gliclazide+Metformin 60mg/500mg Tablet :

Should you forget a StayHappi Gliclazide+Metformin 60mg/500mg Tablet, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.

Facts to Know About StayHappi Gliclazide+Metformin 60mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on StayHappi Gliclazide+Metformin 60mg/500mg Tablet

StayHappi Gliclazide+Metformin 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets can cause lactic acidosis (MALA—Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. While rare, this risk is heightened in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of StayHappi Gliclazide+Metformin 60mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets are contraindicated in patients allergic to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with StayHappi Gliclazide+Metformin 60mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
StayHappi Gliclazide+Metformin 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excess lactic acid in the blood. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Long-term use of StayHappi Gliclazide+Metformin 60mg/500mg Tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems—ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
StayHappi Gliclazide+Metformin 60mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with StayHappi Gliclazide+Metformin 60mg/500mg tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
StayHappi Gliclazide+Metf...
48
MRP 55
12% off